New Jersey Senate Bill S1854

New Jersey 2022-2023 Regular Session

• Introduced: 2/28/22
• Refer: 2/28/22

Caption

Concerns cigarette manufacturers and production of certain tobacco products using roll-your-own tobacco machines at retail establishments within this State.

Impact

This legislative measure is poised to significantly impact state law by expanding the definition of tobacco manufacturers to include operators of RYO machines. Consequently, it imposes the same taxes and regulations applicable to traditional cigarette manufacturers on those who operate these machines. By doing so, the bill seeks to implement stricter control over the sale and production of tobacco products and ensure that health warnings and compliance measures are consistently applied across different types of cigarette production.

Summary

Senate Bill S1854 addresses the regulation of cigarette manufacturing, specifically regarding the production of tobacco products using roll-your-own (RYO) cigarette-making machines located in retail establishments across New Jersey. The bill establishes that those maintaining RYO machines for consumer use will be considered manufacturers of cigarettes, thereby subjecting them to existing state cigarette manufacturing regulations such as the Cigarette Tax Act, as well as federal requirements under the national tobacco Master Settlement Agreement. This move aims to regulate this relatively new trend within the tobacco industry and ensure compliance with health and safety standards.

Contention

The enactment of S1854 may provoke discussion among stakeholders due to the implications it has for retail establishments that utilize RYO machines. Advocates of the bill argue that this regulation is essential for consumer protection and to mitigate potential health risks associated with self-manufactured cigarettes. On the other hand, critics may contend that this could lead to increased operational costs for retailers and potentially limit consumer access to affordable tobacco products. The balance between health regulation and consumer choice is likely to be a central point of contention as the bill progresses.